FDA Orders Tubes of the Product "Age Intervention Eyelash" Seized

The US Food and Drug Administration had the US Marshall seize 12,000 tubes of Age Intervention Eyelash due to concerns over the products' safety. The 12,000 tubes were worth approximately 2 million dollars. Age Intervention Eyelash, sold by Jan Marini Skin Research, Inc. is claimed by the company to promote eyelash growth.

Because Jan Marini Skin Research claims that their product Age Intervention Eyelash promotes eyelash growth, the FDA considers the product a drug. All drugs must be proven by the FDA to be safe and effective before they are legally allowed to be sold. Age Intervention Eyelash has not been approved by the FDA and is therefore considered by the FDA to be an unapproved drug.

In addition to the FDA considering Age Intervention Eyelash a drug, it also considers it an adulterated cosmetic, because of the fact that it contains a drug named bimatoprost.

The FDA warns about serious potential complications from the use of Age Intervention Eyelash, because Age Intervention Eyelash contains the ingredient bimatoprost. Bimatoprost is an ingredient in a FDA approved prescription drug that treats elevated pressure inside the eye. Patients taking the FDA approved prescription drug containing bimatroprost are in danger if they also use Age Intervention Eyelash. The extra dose of bimatroprost from the Age Intervention Eyelash may decrease the effectiveness of the prescription drug. The decreased effectiveness may increase the risk of optic nerve damage, which could possibly lead to decreased vision or even blindness.

Another serious potential complication with the use of Age Intervention Eyelash is, in some people, Age Intervention Eyelash may also cause swelling of the retina and inflammation of the eye which may cause decreased vision. These complications are due to the ingredient bimatoprost in the product.